메뉴 건너뛰기




Volumn 2, Issue 1, 2015, Pages 38-45

Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-KB and JNK dependent manner

Author keywords

C jun N terminal kinase; Clear cell renal cell carcinoma; Epithelial to mesenchymal transition; Nuclear factor kappa ; Pomegranate extract; Von hippel lindau (VHL) tumor suppressor

Indexed keywords

CADHERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POMEGRANATE EXTRACT; STRESS ACTIVATED PROTEIN KINASE;

EID: 85027874357     PISSN: 22143882     EISSN: 22143890     Source Type: Journal    
DOI: 10.1016/j.ajur.2015.04.009     Document Type: Article
Times cited : (13)

References (30)
  • 3
    • 0037617447 scopus 로고    scopus 로고
    • Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor
    • Baba M, Hirai S, Yamada-Okabe H, Hamada K, Tabuchi H, Kobayashi K, et al. Loss of von Hippel-Lindau protein causes cell density dependent deregulation of CyclinD1 expression through hypoxia-inducible factor. Oncogene 2003;22: 2728-38.
    • (2003) Oncogene , vol.22 , pp. 2728-2738
    • Baba, M.1    Hirai, S.2    Yamada-Okabe, H.3    Hamada, K.4    Tabuchi, H.5    Kobayashi, K.6
  • 4
    • 0142166332 scopus 로고    scopus 로고
    • Targeting HIF-1 for cancer therapy
    • Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-32.
    • (2003) Nat Rev Cancer , vol.3 , pp. 721-732
    • Semenza, G.L.1
  • 5
    • 0344406232 scopus 로고    scopus 로고
    • Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma
    • Oya M, Takayanagi A, Horiguchi A, Mizuno R, Ohtsubo M, Marumo K, et al. Increased nuclear factor-kappa B activation is related to the tumor development of renal cell carcinoma. Carcinogenesis 2003;24:377-84.
    • (2003) Carcinogenesis , vol.24 , pp. 377-384
    • Oya, M.1    Takayanagi, A.2    Horiguchi, A.3    Mizuno, R.4    Ohtsubo, M.5    Marumo, K.6
  • 6
    • 34948883495 scopus 로고    scopus 로고
    • PVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2
    • Yang H, Minamishima YA, Yan Q, Schlisio S, Ebert BL, Zhang X, et al. pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. Mol Cell 2007;28:15-27.
    • (2007) Mol Cell , vol.28 , pp. 15-27
    • Yang, H.1    Minamishima, Y.A.2    Yan, Q.3    Schlisio, S.4    Ebert, B.L.5    Zhang, X.6
  • 7
    • 14944366562 scopus 로고    scopus 로고
    • VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NFkappaB- dependent mechanism
    • An J, Fisher M, Rettig MB. VHL expression in renal cell carcinoma sensitizes to bortezomib (PS-341) through an NFkappaB- dependent mechanism. Oncogene 2005;24:1563-70.
    • (2005) Oncogene , vol.24 , pp. 1563-1570
    • An, J.1    Fisher, M.2    Rettig, M.B.3
  • 8
    • 23844527189 scopus 로고    scopus 로고
    • Mechanism of von Hippel-Lindau Proteinmediated suppression of nuclear factor kappa B (NF-kB) activity
    • An J, Rettig MB. Mechanism of von Hippel-Lindau Proteinmediated suppression of nuclear factor kappa B (NF-kB) activity. Mol Cell Biol 2005;25:7546-56.
    • (2005) Mol Cell Biol , vol.25 , pp. 7546-7556
    • An, J.1    Rettig, M.B.2
  • 9
    • 4444301713 scopus 로고    scopus 로고
    • Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent
    • An J, Sun Y, Fisher M, Rettig MB. Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent. Mol Cancer Ther 2004;3: 727-36.
    • (2004) Mol Cancer Ther , vol.3 , pp. 727-736
    • An, J.1    Sun, Y.2    Fisher, M.3    Rettig, M.B.4
  • 10
    • 84874334347 scopus 로고    scopus 로고
    • Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma
    • An J, Liu H, Magyar CE, Guo Y, Veena MS, Srivatsan ES, et al. Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinoma. Cancer Res 2013;73:1374-85.
    • (2013) Cancer Res , vol.73 , pp. 1374-1385
    • An, J.1    Liu, H.2    Magyar, C.E.3    Guo, Y.4    Veena, M.S.5    Srivatsan, E.S.6
  • 11
    • 14744277141 scopus 로고    scopus 로고
    • Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign
    • Afaq F, Malik A, Syed D, Maes D, Matsui MS, Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol 2005;81: 38-45.
    • (2005) Photochem Photobiol , vol.81 , pp. 38-45
    • Afaq, F.1    Malik, A.2    Syed, D.3    Maes, D.4    Matsui, M.S.5    Mukhtar, H.6
  • 12
    • 24744432725 scopus 로고    scopus 로고
    • Extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro
    • Ahmed S, Wang N, Hafeez BB, Cheruvu VK, Haqqi TM. Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro. J Nutr 2005;135:2096-102.
    • (2005) J Nutr , vol.135 , pp. 2096-2102
    • Ahmed, S.1    Wang, N.2    Hafeez, B.B.3    Cheruvu, V.K.4    Haqqi, T.M.P.G.L.5
  • 13
    • 0036884292 scopus 로고    scopus 로고
    • A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants
    • Schubert SY, Neeman I, Resnick N. A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J Off Publ Fed Am Soc Exp Biol 2002;16:1931-3.
    • (2002) FASEB J off Publ Fed Am Soc Exp Biol , vol.16 , pp. 1931-1933
    • Schubert, S.Y.1    Neeman, I.2    Resnick, N.3
  • 14
    • 54049157928 scopus 로고    scopus 로고
    • Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism
    • Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, et al. Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol Cancer Ther 2008;7:2662-71.
    • (2008) Mol Cancer Ther , vol.7 , pp. 2662-2671
    • Rettig, M.B.1    Heber, D.2    An, J.3    Seeram, N.P.4    Rao, J.Y.5    Liu, H.6
  • 15
    • 61849149335 scopus 로고    scopus 로고
    • Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of proinflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells
    • London, England
    • Rasheed Z, Akhtar N, Anbazhagan AN, Ramamurthy S, Shukla M, Haqqi TM. Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of proinflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells. J Inflamm (London, England) 2009;6:1.
    • (2009) J Inflamm , vol.6 , pp. 1
    • Rasheed, Z.1    Akhtar, N.2    Anbazhagan, A.N.3    Ramamurthy, S.4    Shukla, M.5    Haqqi, T.M.6
  • 17
    • 33749494522 scopus 로고    scopus 로고
    • Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours
    • Seeram NP, Henning SM, Zhang Y, Suchard M, Li Z, Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr 2006;136:2481-5.
    • (2006) J Nutr , vol.136 , pp. 2481-2485
    • Seeram, N.P.1    Henning, S.M.2    Zhang, Y.3    Suchard, M.4    Li, Z.5    Heber, D.6
  • 18
    • 30044432434 scopus 로고    scopus 로고
    • Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
    • Thomas GV, Tran C, Mellinghoff IK, Welsbie DS, Chan E, Fueger B, et al. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat Med 2006;12: 122-7.
    • (2006) Nat Med , vol.12 , pp. 122-127
    • Thomas, G.V.1    Tran, C.2    Mellinghoff, I.K.3    Welsbie, D.S.4    Chan, E.5    Fueger, B.6
  • 19
    • 54549103311 scopus 로고    scopus 로고
    • Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation
    • An J, Mo D, Liu H, Veena MS, Srivatsan ES, Massoumi R, et al. Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell 2008;14: 394-407.
    • (2008) Cancer Cell , vol.14 , pp. 394-407
    • An, J.1    Mo, D.2    Liu, H.3    Veena, M.S.4    Srivatsan, E.S.5    Massoumi, R.6
  • 20
    • 76549111028 scopus 로고    scopus 로고
    • NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas
    • Pantuck AJ, An J, Liu H, Rettig MB. NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas. Cancer Res 70:752-61.
    • Cancer Res , vol.70 , pp. 752-761
    • Pantuck, A.J.1    An, J.2    Liu, H.3    Rettig, M.B.4
  • 21
    • 0035963273 scopus 로고    scopus 로고
    • Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells
    • Oya M, Ohtsubo M, Takayanagi A, Tachibana M, Shimizu N, Murai M. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene 2001;20:3888-96.
    • (2001) Oncogene , vol.20 , pp. 3888-3896
    • Oya, M.1    Ohtsubo, M.2    Takayanagi, A.3    Tachibana, M.4    Shimizu, N.5    Murai, M.6
  • 22
    • 68349125561 scopus 로고    scopus 로고
    • Anchorage-independent cell growth signature identifies tumors with metastatic potential
    • Mori S, Chang JT, Andrechek ER, Matsumura N, Baba T, Yao G, et al. Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene 2009;28: 2796-805.
    • (2009) Oncogene , vol.28 , pp. 2796-2805
    • Mori, S.1    Chang, J.T.2    Andrechek, E.R.3    Matsumura, N.4    Baba, T.5    Yao, G.6
  • 23
    • 84864936038 scopus 로고    scopus 로고
    • Novel agents and approaches for advanced renal cell carcinoma
    • Figlin R, Sternberg C, Wood CG. Novel agents and approaches for advanced renal cell carcinoma. J Urol 2012;188:707-15.
    • (2012) J Urol , vol.188 , pp. 707-715
    • Figlin, R.1    Sternberg, C.2    Wood, C.G.3
  • 26
    • 7944225649 scopus 로고    scopus 로고
    • Management of renal masses in patients medically unsuitable for nephrectomyenatural history, complications, and outcome
    • Lamb GW, Bromwich EJ, Vasey P, Aitchison M. Management of renal masses in patients medically unsuitable for nephrectomyenatural history, complications, and outcome. Urology 2004;64:909-13.
    • (2004) Urology , vol.64 , pp. 909-913
    • Lamb, G.W.1    Bromwich, E.J.2    Vasey, P.3    Aitchison, M.4
  • 27
    • 0028823087 scopus 로고
    • Small renal parenchymal neoplasms: Further observations on growth
    • Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology 1995;197:589-97.
    • (1995) Radiology , vol.197 , pp. 589-597
    • Bosniak, M.A.1    Birnbaum, B.A.2    Krinsky, G.A.3    Waisman, J.4
  • 30
    • 3042743273 scopus 로고    scopus 로고
    • Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy
    • Wehle MJ, Thiel DD, Petrou SP, Young PR, Frank I, Karsteadt N. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 2004;64:49-52.
    • (2004) Urology , vol.64 , pp. 49-52
    • Wehle, M.J.1    Thiel, D.D.2    Petrou, S.P.3    Young, P.R.4    Frank, I.5    Karsteadt, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.